Johnson & Johnson to acquire Proteologix for $850 million
(Reuters) - Johnson & Johnson on Thursday said it would acquire privately held Proteologix for $850 million in cash, with potential for an additional milestone payment. (Reporting by Sriparna Roy in Bengaluru; Editing by Anil D'Silva)
5h ago
Lilly's weekly insulin succeeds in late-stage studies
(Reuters) - Eli Lilly said on Thursday that its once-weekly insulin efsitora met the main goals in two late-stage trials evaluating it in people with type 2 diabetes. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)
6h ago
Thai cannabis groups urge government to rethink plan to re-criminalise marijuana
BANGKOK (Reuters) - Dozens of Thai cannabis advocates urged the government on Thursday to abandon its plans to re-list marijuana as an illegal narcotic, a week after it announced its dramatic policy U-turn just two years after de-criminalising it. ...
7h ago
Roche shares gain on obesity drug results from early-stage trial
(Reuters) - Roche shares gained 4.7% at the market open on Thursday after an early-stage trial showed that the obesity drug candidate by newly acquired Carmot Therapeutics led to significant weight loss. The Swiss drugmaker said the study in the fi...
9h ago
AstraZeneca's investigational COVID drug meets primary goals in late-stage study
(Reuters) - AstraZeneca said on Thursday its investigational drug, sipavibart, met primary goals in preventing COVID-19 in immunocompromised patients in a late-stage trial. (Reporting by Eva Mathews in Bengaluru; Editing by Sherry Jacob-Phillips)
10h ago
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports
(Reuters) - Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, the Financial Times reported on Thursday. (Rep...
12h ago
US FDA approves expanded use of Bristol's cancer cell therapy
(Reuters) -The U.S. health regulator said on Wednesday it has approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer that has returned or has not responded to prior treat...
19h ago
Canada says its commercial milk tests negative for bird flu
WASHINGTON (Reuters) - Canadian government officials said samples of commercially sold milk as of May 14 have shown "no evidence" of H5N1 bird flu after enhanced testing aimed at alleviating Canadians concerns following the virus' detection in some...
23h ago
UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down
(Reuters) - Britain's Pharmacy2U said on Wednesday it had cut the prices of weight-loss medication Wegovy and Mounjaro, becoming the latest in a slew of online pharmacies and slimming clinics to do so as initial supply shortages of the drugs ease ...
May 15, 2024
Britons warned to boil water on concern over parasite contamination in Devon areas
LONDON (Reuters) - Residents in part of Devon in southwestern England were warned on Wednesday to boil water before consuming it after the region's water utility found traces of an intestinal parasite that can cause diarrhoea and vomiting. South We...
May 15, 2024
Walgreens launches own brand of opioid overdose reversal drug
(Reuters) - U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available over-the-counter (OTC). The launch comes weeks after Walgreens'...
May 15, 2024
WHO prequalifies new dengue vaccine
(Reuters) - The World Health Organization (WHO) said on Wednesday that it had prequalified Takeda Pharmaceuticals' dengue vaccine. (Reporting by Christy Santhosh; Editing by Tasim Zahid)
May 15, 2024
Imperial Brands CEO: U.S. menthol cigarette ban likely years away
LONDON (Reuters) - The outcome of moves to ban menthol cigarettes in the United States remains uncertain but implementation will likely take years, Imperial Brands Chief Executive Stefan Bomhard said on Wednesday. The Biden administration delayed a...
May 15, 2024
Getinge limits sale of heart devices in the US after FDA warning
(Reuters) - Sweden's Getinge will limit sales of some of its heart products in the U.S., the medical equipment maker said late on Tuesday, after recent advice from the U.S. Food and Drug Administration (FDA) to move away from its devices. "We have ...
May 15, 2024
No shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk says
COPENHAGEN (Reuters) - Novo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier warning by the Danish Medicines Agency of strained supply of two separate doses in the coming weeks, the company said. The D...
May 15, 2024
Novo Nordisk owner buys majority stake in Austrian life science tools company
By Maggie Fick LONDON (Reuters) - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it would buy a controlling stake of about 60% in Single Use Support, an Austria-based life science tools compan...
May 15, 2024
Roche says FDA approves HPV self-test in US
BERLIN (Reuters) - Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit. Screening for HPV can help identify women who are at risk of developing cervical canc...
May 15, 2024
Merck KGaA's Q1 adjusted profit declines less than feared
By Ludwig Burger FRANKFURT (Reuters) - Merck KGaA on Wednesday reported better-than-expected adjusted earnings, helped by strong demand for its pharmaceuticals and amid currency-adjusted sales growth in semiconductor materials. The German diversifi...
May 15, 2024
Taiwan says WHO should let it attend all its meetings
TAIPEI (Reuters) - Taiwan Foreign Minister Joseph Wu called on the World Health Organization on Wednesday to allow the island to attend all its meetings if it is serious about its goal of "Health for All", ahead of a key summit Taipei wants to take...
May 15, 2024
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
(Reuters) - Eisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis to the US health regulator for a marketing application of a subcutaneous form of their Alzheimer's disease drug Leqembi. T...
May 14, 2024
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
(Reuters) - Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit versions of its popular diabetes drug Mounjaro and weight loss treatment Zepbound, the drugmaker said on Tuesday. As part of the deal, Totality Medis...
May 14, 2024
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say
By Svea Herbst-Bayliss (Reuters) - Activist investor Jana Partners built a new stake in U.S. diagnostics company QuidelOrtho during the first quarter, sources familiar with the hedge fund's position told Reuters. It is unclear whether the hedge fun...
May 14, 2024
Grifols swings to profit, says debt reduction on track
By Joan Faus BARCELONA (Reuters) - Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 million) from a year-ago loss, and said on Tuesday it was on track to meet its 2024 outlook, including cutting debt. Grifols, ...
May 14, 2024
CDC makes public influenza A wastewater data to assist bird flu probe
(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday released data on influenza A found in wastewater in a public dashboard that could assist in tracking the outbreak of H5N1 bird flu that has infected cattle herds. Las...
May 14, 2024
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
(Reuters) - The U.S. Food and Drug Administration has declined to approve the expanded use of Dynavax Technologies' hepatitis B vaccine in patients undergoing hemodialysis, the company said on Tuesday. (Reporting by Christy Santhosh and Pratik Jai...
May 14, 2024